arrow
B

Brian F. Chapin

university of texas system
H指数:31
被引数:4,264

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer

最佳全身疗法与最佳全身疗法对转移性前列腺癌原发肿瘤进行确定性治疗的2期随机对照试验

2026-03-140
PRE
Prostate Cancer, Version 3.2026

前列腺癌,版本3.2026,NCCN肿瘤学临床实践指南

2025-11-012
PRE
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

持续性雄激素剥夺疗法联合或未联合转移灶定向治疗寡转移性前列腺癌:多中心II期随机EXTEND试验

2025-07-310
PRE
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis

随机化Ⅱ期临床试验:针对出现淋巴结转移的前列腺癌患者,比较术前雄激素剥夺疗法联合或不联合Axitinib的治疗效果

2025-07-120
PRE
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
2024-11-090
OAAI
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates

阿帕鲁胺治疗中危前列腺癌的II期试验及其分子相关性

2024-06-041
PRE
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy

前列腺癌的挽救治疗: AUA/ASTRO/SUO指南第二部分: 原发性根治性前列腺切除术后非转移性生化复发的治疗

2024-04-014
PRE
Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
2024-04-0124
OA
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions

前列腺癌的挽救治疗: AUA/ASTRO/SUO指南第三部分: 放疗或局部治疗后的挽救治疗,盆腔淋巴结复发和寡转移以及未来方向

2024-04-014
PRE
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy

前列腺癌的挽救治疗: AUA/ASTRO/SUO指南第一部分: 前列腺癌根治术后怀疑生化复发时的介绍和治疗决策

2024-04-018
PRE